Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies,
Department of Chemical Engineering,
Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering
Avi Schroeder is an Associate Professor of Chemical Engineering at the Technion – Israel Institute of Technology where he heads the Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies (https://www.schroederlab.com/ ).
Dr. Schroeder conducted his Postdoctoral studies at the Massachusetts Institute of Technology, and his PhD jointly at the Hebrew and Ben Gurion Universities.
Avi is the recipient of more than 30 national and international awards, including named a KAVLI Fellow, the Intel Nanotechnology-, TEVA Pharmaceuticals-, and the Wolf Foundation Krill Awards. Avi is the author of more than 50 research papers inventor of 19 patents and co-founder of several startup companies based on these discoveries.
Schroeder is a member of Israel Young National Academy of Sciences, and the President of the Israel Institute of Chemical Engineers.
Liposomes act as effective biolubricants for friction reduction in human synovial joints.
Langmuir : the ACS journal of surfaces and colloids Jan, 2010 | Pubmed ID: 20014818
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.
Nature nanotechnology Aug, 2014 | Pubmed ID: 24813696
Small RNA combination therapy for lung cancer.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2014 | Pubmed ID: 25114235
Microneedles for drug delivery via the gastrointestinal tract.
Journal of pharmaceutical sciences Feb, 2015 | Pubmed ID: 25250829
Ultrasound-mediated gastrointestinal drug delivery.
Science translational medicine Oct, 2015 | Pubmed ID: 26491078
Melanoma miRNA trafficking controls tumour primary niche formation.
Nature cell biology 09, 2016 | Pubmed ID: 27548915
Autonomous bacterial nanoswimmers target cancer.
Journal of controlled release : official journal of the Controlled Release Society 07, 2017 | Pubmed ID: 27744036
A Simple and Rapid Method for Preparing a Cell-Free Bacterial Lysate for Protein Synthesis.
PloS one , 2016 | Pubmed ID: 27768741
Theranostic barcoded nanoparticles for personalized cancer medicine.
Nature communications 11, 2016 | Pubmed ID: 27830705
Nanoparticles target early-stage breast cancer metastasis in vivo.
Nanotechnology Oct, 2017 | Pubmed ID: 28872058
Synthetic Cells Synthesize Therapeutic Proteins inside Tumors.
Advanced healthcare materials 05, 2018 | Pubmed ID: 29283226
Mucoadhesive alginate pastes with embedded liposomes for local oral drug delivery.
International journal of biological macromolecules May, 2018 | Pubmed ID: 29292143
Proteolytic Nanoparticles Replace a Surgical Blade by Controllably Remodeling the Oral Connective Tissue.
ACS nano 02, 2018 | Pubmed ID: 29365250
Therapeutic nanoparticles penetrate leaves and deliver nutrients to agricultural crops.
Scientific reports 05, 2018 | Pubmed ID: 29773873
Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.
Journal of controlled release : official journal of the Controlled Release Society 02, 2019 | Pubmed ID: 30615983
Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells.
Journal of controlled release : official journal of the Controlled Release Society Aug, 2019 | Pubmed ID: 31238049
Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
Advanced materials (Deerfield Beach, Fla.) Apr, 2020 | Pubmed ID: 31286573
Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems.
Chemical engineering journal (Lausanne, Switzerland : 1996) May, 2018 | Pubmed ID: 31384170
Mucoadhesive Hybrid Polymer/Liposome Pastes Based on Modified Polysaccharides.
Journal of pharmaceutical sciences Dec, 2019 | Pubmed ID: 31491439
Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors.
ACS nano 10, 2019 | Pubmed ID: 31503443
Intravital imaging of vascular anomalies and extracellular matrix remodeling in orthotopic pancreatic tumors.
International journal of cancer 04, 2020 | Pubmed ID: 31661557
Omer Adir*,1,2,
Noga Sharf-Pauker*,1,2,
Gal Chen*,1,3,
Maya Kaduri1,
Nitzan Krinsky1,3,
Janna Shainsky-Roitman1,
Jeny Shklover1,
Avi Schroeder1
1Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology,
2The Norman Seiden Multidisciplinary Program for Nanoscience and Nanotechnology, Technion - Israel Institute of Technology,
3The Interdisciplinary Program for Biotechnology, Technion - Israel Institute of Technology
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved